Enoxaparin
DVT/PE treatment, ACS adjunct, VTE prophylaxis
High-alert medication
- Antithrombotic agents - LMWH (class)
Indications
- DVT/PE treatment
- ACS adjunct
- VTE prophylaxis
Adult dosing
- treatment: dose: 1; unit: mg/kg; route: SC; interval: q12h; weightBased: true; maxDose: 150; maxDoseAbsolute: true
- acs: dose: 1; unit: mg/kg; route: SC; interval: q12h (with initial 30mg IV bolus); weightBased: true; maxDose: 150; maxDoseAbsolute: true
- prophylaxis: dose: 40; unit: mg SC daily; route: SC; fixed: true
Pediatric dosing
- treatment: dose: 1; unit: mg/kg; route: SC; interval: q12h; weightBased: true
Renal adjustment
- mild: No change; moderate: No change; severe: Reduce to 1mg/kg q24h; failure: Avoid — use UFH; hemodialysis: Avoid — use UFH
Hepatic adjustment
- Consult pharmacy/current label
Contraindications
- Active major bleeding
- HIT history
- CrCl <15
Clinical pearls
- Dose reduction required in renal impairment — CrCl <30 use q24h dosing
- Anti-Xa level for monitoring if needed (obese, renal impairment, pregnancy)
- Partial reversal with protamine — only ~60% effective
- Do NOT interchange with other LMWHs — not equivalent
Source and review
- ACCP Guidelines 2016; AHA/ACC NSTEMI Guidelines. Last reviewed: 2024-11-01
RotationRx · Drugs · Scores · Protocols · Diagnoses · Specialties